The global Water for Injection (WFI) market size is predicted to grow from US$ 25630 million in 2025 to US$ 37250 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Water for Injection (WFI) refers to a highly purified water used in the production of pharmaceuticals and medical devices. It is prepared according to rigorous quality standards and must meet the requirements specified by pharmacopoeial authorities. WFI should be free from impurities, such as microorganisms, endotoxins, and particles, and be suitable for parenteral administration (administered through injection). WFI is typically used in the formulation, manufacturing, and testing of pharmaceutical products, as well as for the cleaning and sterilization of equipment and packaging materials.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The “Water for Injection (WFI) Industry Forecast” looks at past sales and reviews total world Water for Injection (WFI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Water for Injection (WFI) sales for 2025 through 2031. With Water for Injection (WFI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Water for Injection (WFI) industry.
This Insight Report provides a comprehensive analysis of the global Water for Injection (WFI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Water for Injection (WFI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Water for Injection (WFI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Water for Injection (WFI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Water for Injection (WFI).
This report presents a comprehensive overview, market shares, and growth opportunities of Water for Injection (WFI) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Bacteriostatic Water for Injection
Sterile Water for Injection
Segmentation by Application:
Research Institutes
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Johnson and Johnson
Acella Pharmaceuticals
Merck KGaA
AdvaCare Pharma
B. Braun SE
FUJIFILM Holdings
GlaxoSmithKline
Merit Healthcare International
Novartis AG
Pfizer
Pharma Cure Laboratories
Sanofi
Zhejiang Tianrui Pharmaceutical
Zhuhai Tongyuan Pharmaceutical
Shandong Kanghua
Key Questions Addressed in this Report
What is the 10-year outlook for the global Water for Injection (WFI) market?
What factors are driving Water for Injection (WFI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Water for Injection (WFI) market opportunities vary by end market size?
How does Water for Injection (WFI) break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Water for Injection (WFI) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Water for Injection (WFI) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Water for Injection (WFI) by Country/Region, 2020, 2024 & 2031
2.2 Water for Injection (WFI) Segment by Type
2.2.1 Bacteriostatic Water for Injection
2.2.2 Sterile Water for Injection
2.3 Water for Injection (WFI) Sales by Type
2.3.1 Global Water for Injection (WFI) Sales Market Share by Type (2020-2025)
2.3.2 Global Water for Injection (WFI) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Water for Injection (WFI) Sale Price by Type (2020-2025)
2.4 Water for Injection (WFI) Segment by Application
2.4.1 Research Institutes
2.4.2 Hospitals
2.4.3 Clinics
2.4.4 Others
2.5 Water for Injection (WFI) Sales by Application
2.5.1 Global Water for Injection (WFI) Sale Market Share by Application (2020-2025)
2.5.2 Global Water for Injection (WFI) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Water for Injection (WFI) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Water for Injection (WFI) Breakdown Data by Company
3.1.1 Global Water for Injection (WFI) Annual Sales by Company (2020-2025)
3.1.2 Global Water for Injection (WFI) Sales Market Share by Company (2020-2025)
3.2 Global Water for Injection (WFI) Annual Revenue by Company (2020-2025)
3.2.1 Global Water for Injection (WFI) Revenue by Company (2020-2025)
3.2.2 Global Water for Injection (WFI) Revenue Market Share by Company (2020-2025)
3.3 Global Water for Injection (WFI) Sale Price by Company
3.4 Key Manufacturers Water for Injection (WFI) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Water for Injection (WFI) Product Location Distribution
3.4.2 Players Water for Injection (WFI) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Water for Injection (WFI) by Geographic Region
4.1 World Historic Water for Injection (WFI) Market Size by Geographic Region (2020-2025)
4.1.1 Global Water for Injection (WFI) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Water for Injection (WFI) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Water for Injection (WFI) Market Size by Country/Region (2020-2025)
4.2.1 Global Water for Injection (WFI) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Water for Injection (WFI) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Water for Injection (WFI) Sales Growth
4.4 APAC Water for Injection (WFI) Sales Growth
4.5 Europe Water for Injection (WFI) Sales Growth
4.6 Middle East & Africa Water for Injection (WFI) Sales Growth
5 Americas
5.1 Americas Water for Injection (WFI) Sales by Country
5.1.1 Americas Water for Injection (WFI) Sales by Country (2020-2025)
5.1.2 Americas Water for Injection (WFI) Revenue by Country (2020-2025)
5.2 Americas Water for Injection (WFI) Sales by Type (2020-2025)
5.3 Americas Water for Injection (WFI) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Water for Injection (WFI) Sales by Region
6.1.1 APAC Water for Injection (WFI) Sales by Region (2020-2025)
6.1.2 APAC Water for Injection (WFI) Revenue by Region (2020-2025)
6.2 APAC Water for Injection (WFI) Sales by Type (2020-2025)
6.3 APAC Water for Injection (WFI) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Water for Injection (WFI) by Country
7.1.1 Europe Water for Injection (WFI) Sales by Country (2020-2025)
7.1.2 Europe Water for Injection (WFI) Revenue by Country (2020-2025)
7.2 Europe Water for Injection (WFI) Sales by Type (2020-2025)
7.3 Europe Water for Injection (WFI) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Water for Injection (WFI) by Country
8.1.1 Middle East & Africa Water for Injection (WFI) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Water for Injection (WFI) Revenue by Country (2020-2025)
8.2 Middle East & Africa Water for Injection (WFI) Sales by Type (2020-2025)
8.3 Middle East & Africa Water for Injection (WFI) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Water for Injection (WFI)
10.3 Manufacturing Process Analysis of Water for Injection (WFI)
10.4 Industry Chain Structure of Water for Injection (WFI)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Water for Injection (WFI) Distributors
11.3 Water for Injection (WFI) Customer
12 World Forecast Review for Water for Injection (WFI) by Geographic Region
12.1 Global Water for Injection (WFI) Market Size Forecast by Region
12.1.1 Global Water for Injection (WFI) Forecast by Region (2026-2031)
12.1.2 Global Water for Injection (WFI) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Water for Injection (WFI) Forecast by Type (2026-2031)
12.7 Global Water for Injection (WFI) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Water for Injection (WFI) Product Portfolios and Specifications
13.1.3 Abbott Laboratories Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Johnson and Johnson
13.2.1 Johnson and Johnson Company Information
13.2.2 Johnson and Johnson Water for Injection (WFI) Product Portfolios and Specifications
13.2.3 Johnson and Johnson Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson and Johnson Main Business Overview
13.2.5 Johnson and Johnson Latest Developments
13.3 Acella Pharmaceuticals
13.3.1 Acella Pharmaceuticals Company Information
13.3.2 Acella Pharmaceuticals Water for Injection (WFI) Product Portfolios and Specifications
13.3.3 Acella Pharmaceuticals Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Acella Pharmaceuticals Main Business Overview
13.3.5 Acella Pharmaceuticals Latest Developments
13.4 Merck KGaA
13.4.1 Merck KGaA Company Information
13.4.2 Merck KGaA Water for Injection (WFI) Product Portfolios and Specifications
13.4.3 Merck KGaA Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck KGaA Main Business Overview
13.4.5 Merck KGaA Latest Developments
13.5 AdvaCare Pharma
13.5.1 AdvaCare Pharma Company Information
13.5.2 AdvaCare Pharma Water for Injection (WFI) Product Portfolios and Specifications
13.5.3 AdvaCare Pharma Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AdvaCare Pharma Main Business Overview
13.5.5 AdvaCare Pharma Latest Developments
13.6 B. Braun SE
13.6.1 B. Braun SE Company Information
13.6.2 B. Braun SE Water for Injection (WFI) Product Portfolios and Specifications
13.6.3 B. Braun SE Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 B. Braun SE Main Business Overview
13.6.5 B. Braun SE Latest Developments
13.7 FUJIFILM Holdings
13.7.1 FUJIFILM Holdings Company Information
13.7.2 FUJIFILM Holdings Water for Injection (WFI) Product Portfolios and Specifications
13.7.3 FUJIFILM Holdings Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 FUJIFILM Holdings Main Business Overview
13.7.5 FUJIFILM Holdings Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Water for Injection (WFI) Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Merit Healthcare International
13.9.1 Merit Healthcare International Company Information
13.9.2 Merit Healthcare International Water for Injection (WFI) Product Portfolios and Specifications
13.9.3 Merit Healthcare International Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merit Healthcare International Main Business Overview
13.9.5 Merit Healthcare International Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Water for Injection (WFI) Product Portfolios and Specifications
13.10.3 Novartis AG Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Pfizer
13.11.1 Pfizer Company Information
13.11.2 Pfizer Water for Injection (WFI) Product Portfolios and Specifications
13.11.3 Pfizer Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pfizer Main Business Overview
13.11.5 Pfizer Latest Developments
13.12 Pharma Cure Laboratories
13.12.1 Pharma Cure Laboratories Company Information
13.12.2 Pharma Cure Laboratories Water for Injection (WFI) Product Portfolios and Specifications
13.12.3 Pharma Cure Laboratories Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Pharma Cure Laboratories Main Business Overview
13.12.5 Pharma Cure Laboratories Latest Developments
13.13 Sanofi
13.13.1 Sanofi Company Information
13.13.2 Sanofi Water for Injection (WFI) Product Portfolios and Specifications
13.13.3 Sanofi Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sanofi Main Business Overview
13.13.5 Sanofi Latest Developments
13.14 Zhejiang Tianrui Pharmaceutical
13.14.1 Zhejiang Tianrui Pharmaceutical Company Information
13.14.2 Zhejiang Tianrui Pharmaceutical Water for Injection (WFI) Product Portfolios and Specifications
13.14.3 Zhejiang Tianrui Pharmaceutical Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Zhejiang Tianrui Pharmaceutical Main Business Overview
13.14.5 Zhejiang Tianrui Pharmaceutical Latest Developments
13.15 Zhuhai Tongyuan Pharmaceutical
13.15.1 Zhuhai Tongyuan Pharmaceutical Company Information
13.15.2 Zhuhai Tongyuan Pharmaceutical Water for Injection (WFI) Product Portfolios and Specifications
13.15.3 Zhuhai Tongyuan Pharmaceutical Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Zhuhai Tongyuan Pharmaceutical Main Business Overview
13.15.5 Zhuhai Tongyuan Pharmaceutical Latest Developments
13.16 Shandong Kanghua
13.16.1 Shandong Kanghua Company Information
13.16.2 Shandong Kanghua Water for Injection (WFI) Product Portfolios and Specifications
13.16.3 Shandong Kanghua Water for Injection (WFI) Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Shandong Kanghua Main Business Overview
13.16.5 Shandong Kanghua Latest Developments
14 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
